- $37.23m
- $42.56m
- $13.97m
- 22
- 21
- 46
- 19
Annual income statement for Northann, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 13.1 | 34.5 | 21 | 14 |
Cost of Revenue | ||||
Gross Profit | 4.52 | 5.83 | 5.75 | 1.21 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Total Operating Expenses | 12.5 | 33.4 | 18.9 | 18.7 |
Operating Profit | 0.549 | 1.15 | 2.08 | -4.76 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 0.404 | 0.879 | 1.06 | -7.12 |
Provision for Income Taxes | ||||
Net Income After Taxes | 0.444 | 0.323 | 0.929 | -7.13 |
Net Income Before Extraordinary Items | ||||
Net Income | 0.444 | 0.323 | 0.929 | -7.13 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 0.444 | 0.323 | 0.929 | -7.13 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.019 | 0.014 | 0.04 | -0.352 |
Dividends per Share |